Jazz Pharmaceuticals plc
JAZZ
$244.96
-$0.89-0.36%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
8/14/2026
-
MarketBeat
8/13/2026
-
Zacks Investment Research
8/13/2026
-
Simply Wall St
8/13/2026
-
TipRanks
8/13/2026
-
TipRanks
8/12/2026
-
TheStreet - Investing
8/12/2026
-
Seeking Alpha - Healthcare
8/12/2026
-
Seeking Alpha - Long Ideas
8/12/2026
-
MarketBeat
8/11/2026
-
Zacks Investment Research
8/11/2026
-
CNBC: Healthcare
8/11/2026
-
TipRanks
8/11/2026
-
TipRanks: TheFly
8/11/2026
-
TipRanks
8/11/2026
-
Pharmaceutical Business Review
8/10/2026
-
Zacks Investment Research
8/10/2026
-
Seeking Alpha - Healthcare
8/10/2026
-
SeekingAlpha.com: All News
8/10/2026
-
TipRanks: TheFly
8/10/2026
-
TipRanks: TheFly
8/10/2026
-
PR Newswire
8/10/2026
-
FierceBiotech.com - Biotech
8/10/2026
-
MarketBeat
8/8/2026
-
SeekingAlpha
8/7/2026
-
Zacks Investment Research
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, August 3, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
353 1 634 7800
Address
Waterloo Exchange
Fifth Floor
Waterloo Road
Dublin 4
Dublin, D04 E5W7
Fifth Floor
Waterloo Road
Dublin 4
Dublin, D04 E5W7
Country
Year Founded
Business Description
Sector
--
Industry
--
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or...
more